Prophylactic antigen‐specific T‐cells targeting seven viral and fungal pathogens after allogeneic haemopoietic stem cell transplant

Prophylactic antigen‐specific T‐cells targeting seven viral and fungal pathogens after allogeneic haemopoietic stem cell transplant

Abstract Objectives Adoptive immunotherapy using donor‐derived antigen‐specific T‐cells can prevent and treat infection after allogeneic haemopoietic stem cell transplant (HSCT). Methods We treated 11 patients with a prophylactic infusion of 2 × 107 cells per square metre donor‐derived T‐cells targe...

Full description

Bibliographic Details
Main Authors:	David Jonathan Gottlieb, Leighton Edward Clancy, Barbara Withers, Helen Marie McGuire, Fabio Luciani, Mandeep Singh, Brendan Hughes, Brian Gloss, David Kliman, Chun Kei Kris Ma, Shyam Panicker, David Bishop, Ming‐Celine Dubosq, Ziduo Li, Selmir Avdic, Kenneth Micklethwaite, Emily Blyth
Format:	Article
Language:	English
Published:	Wiley 2021-01-01
Series:	Clinical & Translational Immunology
Subjects:	adoptive immunotherapy allogeneic stem cell transplantation CTL haemopoietic stem cell transplant opportunistic infection systemic fungal infection
Online Access:	https://doi.org/10.1002/cti2.1249

Similar Items

Mass cytometry reveals immune signatures associated with cytomegalovirus (CMV) control in recipients of allogeneic haemopoietic stem cell transplant and CMV‐specific T cells
by: Helen M McGuire, et al.
Published: (2020-01-01)

Haemopoietic stem cell transplantation in Systemic lupus erythematosus: a systematic review
by: Nipun Lakshitha de Silva, et al.
Published: (2019-09-01)

Endocrine Disorders in Childhood Cancer Survivors Treated with Haemopoietic Stem Cell Transplantation
by: Christina Wei, et al.
Published: (2014-06-01)

Occurrence of adenovirus infection and clinical impact in paediatric stem cell transplant recipients
by: Gabriele Bianco, et al.
Published: (2016-10-01)

Harvesting, processing and inventory management of peripheral blood stem cells
by: Mijovic Aleksandar, et al.
Published: (2007-01-01)

Human Cytomegalovirus Latency and Reactivation in Allogeneic Hematopoietic Stem Cell Transplant Recipients
by: Lauren Stern, et al.
Published: (2019-05-01)

Haemopoietic Actions of Justicia secunda Leaf Extracts in Mice
by: Omo Irinmwinuwa, et al.
Published: (2022-09-01)

Psychological empowerment and quality of life in haematopoietic stem cell transplantation patients: A quantitative study
by: Marija Turlinskienė, et al.
Published: (2023-12-01)

Clinical characteristics, risk factors and antiviral treatments of influenza in immunosuppressed inpatients in Beijing during the 2015–2020 influenza seasons
by: Yafen Liu, et al.
Published: (2022-01-01)

Fatigue as Mediator Factor in PTSD-Symptoms after Allogeneic Hematopoietic Stem Cell Transplantation
by: Giulia Di Francesco, et al.
Published: (2023-04-01)

Fibrosis and bone marrow: understanding causation and pathobiology
by: Kanjaksha Ghosh, et al.
Published: (2023-10-01)

Mass Cytometry for the Assessment of Immune Reconstitution After Hematopoietic Stem Cell Transplantation
by: Lauren Stern, et al.
Published: (2018-07-01)

Single-centre experience of allogeneic haemopoietic stem cell transplant in paediatric patients in Cape Town, South Africa
by: A van Eyssen, et al.
Published: (2017-03-01)

Lung transplantation for late-onset non-infectious chronic pulmonary complications of allogenic hematopoietic stem cell transplant
by: Peter Riddell, et al.
Published: (2021-04-01)

Infection profile of patients undergoing autologous bone marrow transplantation in a Brazilian institution
by: Kelli Borges Santos, et al.

Anncaliia algerae Microsporidial Myositis, New South Wales, Australia
by: Gaurav Sutrave, et al.
Published: (2018-08-01)

Infections in Hematopoietic Stem Cell Transplant Recipients and Prevention
by: Ayşegül YEŞİLKAYA, et al.
Published: (2006-06-01)

PARASITIC INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
by: Isidro Jarque, et al.
Published: (2016-07-01)

Increased risk of 100-day and 1-year infection-related mortality and complications in haploidentical stem cell transplantation
by: Chang J, et al.
Published: (2019-05-01)

Mesenchymal stromal cells plus basiliximab improve the response of steroid-refractory acute graft-versus-host disease as a second-line therapy: a multicentre, randomized, controlled trial
by: Haixia Fu, et al.
Published: (2024-02-01)

The reduced incidence of respiratory viral infections in transplant recipients during the COVID-19 pandemic – A retrospective observational cross-sectional analysis of admissions to a tertiary haematology unit
by: Hamzah Z. Farooq, et al.
Published: (2023-11-01)

Circulating cytokine and chemokine patterns associated with cytomegalovirus reactivation after stem cell transplantation
by: Lauren Stern, et al.
Published: (2023-01-01)

Toxoplasmosis in Transplant Recipients, Europe, 2010–2014
by: Florence Robert-Gangneux, et al.
Published: (2018-08-01)

Allorecognition of HLA-C mismatches by CD8+ T cells in hematopoietic stem cell transplantation is a complex interplay between mismatched peptide binding region residues, HLA-C expression and HLA-DPB1 disparities
by: Florence Bettens, et al.
Published: (2016-12-01)

Rhodococcus Infection in Solid Organ and Hematopoietic Stem Cell Transplant Recipients
by: Pascalis Vergidis, et al.
Published: (2017-03-01)

Prophylaxis and Treatment of Infections in Pediatric Stem Cell Transplantation
by: S. Sema ANAK
Published: (2004-06-01)

Virus infections after allogeneic stem cell transplantation in children. Review
by: Kerstin Katharina Rauwolf, et al.
Published: (2023-12-01)

Acute Neurological Involvement after Donor Lymphocyte Infusion for Post-Transplant Viral Infection: The Same Pattern of Novel Cancer Immunotherapy-Related CNS Toxicity?
by: Annalisa Marcuzzi, et al.
Published: (2022-03-01)

COVID‐19‐associated secondary hemophagocytic lymphohistiocytosis requiring hematopoietic cell transplant
by: Jacob R. Greenmyer, et al.
Published: (2022-08-01)

Clinical use of statins in hematopoietic stem cell transplantation: Old drugs and new horizons
by: Mehdi Mohammadi, et al.
Published: (2016-04-01)

Characteristics and Risk Factors for Patients with BK Polyomavirus Infection After Hematopoietic Stem Cell Transplantation
by: Gamze KALIN ÜNÜVAR, et al.
Published: (2022-06-01)

Whole-Genome Approach to Assessing Human Cytomegalovirus Dynamics in Transplant Patients Undergoing Antiviral Therapy
by: Nicolás M. Suárez, et al.
Published: (2020-06-01)

Is there a role for allogeneic haemopoietic stem cell transplants (HSCT) in patients with Hodgkin's disease? Há um papel para o transplante alogênico em paciente com doença de Hodgkin?
by: Andrea Bacigalupo
Published: (2009-08-01)

Invasive pulmonary co-infection caused by Aspergillus sp. and Pneumocystis jirovecii, complicated by Cytomegalovirus reactivation in a patient following second allogeneic hematopoietic stem cell transplantation – Case report
by: Denis Niyazi, et al.
Published: (2023-12-01)

Revisit of the Association between Cytomegalovirus Infection and Invasive Fungal Infection after Allogeneic Hematopoietic Stem Cell Transplantation: A Real-World Analysis from a High CMV Seroprevalence Area
by: Tsung-Jang Yeh, et al.
Published: (2022-04-01)

When Viruses Meet Fungi: Tackling the Enemies in Hematology
by: Alessandro Busca, et al.
Published: (2022-02-01)

Potential Beneficial Effects of Cytomegalovirus Infection after Transplantation
by: Nicolle H. R. Litjens, et al.
Published: (2018-03-01)

Predictors of post traumatic growth in allogeneic hematopoietic stem cell transplantation survivors: a cross-sectional survey
by: Gemma McErlean, et al.
Published: (2023-08-01)

From Upper Respiratory Symptoms to Hemophagocytic Lymphohistiocytosis: Case Report of a Human Adenovirus Infection in Haploidentical Hematopoietic Stem Cell Transplant Recipient
by: Baptiste Demey, et al.
Published: (2021-03-01)

INFECTIOUS COMPLICATIONS, ASSOCIATED WITH MULTI-DRUG RESISTANT BACTERIA IN PATIENTS FOLLOWING HEMATOPOIETIC STEM CELL TRANSPLANTATION – RESISTANCE MECHANISMS AND THERAPEUTIC OPTIONS
by: D. Niyazi
Published: (2023-09-01)